Idiopathic thrombocytopenic purpura;Idiopathische thrombozytopenische purpura (ITP)

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 8, 2007, Pages 383-390

  Schroers, Roland ^a   Duhrsen U ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Idiopathic thrombocytopenic purpura; Thrombocytopenia; Werlhof disease

Indexed keywords

AMG 531; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DANAZOL; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN; RHESUS D ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

COMBINATION CHEMOTHERAPY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PATHOGENESIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; REVIEW; SPLENECTOMY; AGED; CASE REPORT; FEMALE; MALE; PREGNANCY; PREGNANCY COMPLICATION;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROGNOSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY;

EID: 33947715297     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970345     Document Type: Review

References (27)

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995-1008
2. Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 2003; 122: 966-974
3. Andersson PO, Wadenvik H. Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy. Expert Rev Mol Med 2004; 6: 1-17
4. Kuwana M, Ikeda Y. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura. Int J Hematol 2005; 81: 106-112
5. Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol 2006; 133: 364-374
6. Doan CA, Bouroncle BA, Wiseman BK. Idiopathic and secanodary thrombocytopenic purpura: clinical study and evaluation of 382 cases over a period of 28 years. Ann Intern Med 1960; 53: 861-876
7. Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 2005; 56: 425-442
8. Bussel J. Treatment of immune thrombocytopenic purpura in adults. Semin Hematol 2006; 43 (Suppl 5): S3-10
9. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-1935
10. Drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 2004; 103: 390-398
11. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574-596
12. Heilmann L. Hemostasis disorders in obstetrics and gynecology. Hamostaseologie 2004; 24: 252-260
13. George JN, Woolf SH, Raskob GE. Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults: American Society of Hematology. Ann Med 1998; 30: 38-44
14. Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. Ann Hematol 2004; 83: 764-768
15. Cubic S. Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura. Br J Haematol 2003; 120: 909-910
16. Godeau B, Chevret S, Varet B et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 2002; 359: 23-29
17. Bierling P, Godeau B. Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on. Vox Sang 2004; 86: 8-14
18. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004; 104: 2623-2634
19. Penalver FJ, Jimenez-Yuste V, Almagro M et al. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients. Ann Hematol 2006; 85: 400-406
20. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med 2004; 140: 112-120
21. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106: 2244-2251
22. Kappers-Klunne MC, van't Veer MB. Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy. Br J Haematol 2001; 114: 121-125
23. Provan D, Moss AJ, Newland AC, BusselJB. Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura. Am J Hematol 2006; 81: 19-25
24. Huhn RD, Fogarty PF, Nakamura R et al. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood 2003; 101: 71-77
25. Bussel JB, Kuter DJ, George JN et al. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 2006; 355: 1672-1681
26. Vianelli N, Valdre L, Fiacchini M et al. Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. Haematologica 2001; 86: 504-509
27. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 2000; 160: 1630-1638